Trials / Terminated
TerminatedNCT02860481
FSH-R : Diagnostic Application for Localized Tumors in Cancerology
FSH-R (Follicle-stimulating Hormone Receptor ): Diagnostic Application for Localized Tumors in Cancerology
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 95 (actual)
- Sponsor
- Institut Curie · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
FRACTal study is the first exploration of detection of FSHR as a blood biomarker for the diagnosis of cancer. A first cohort will explore several common (e.g. breast, prostate) or rare (e.g. uveal melanoma) cancers, that are frequently treated at Institut Curie. This first cohort will include n=10 patients per histological type except for breast cancer (n=50). 100 patients are expected in this cohort. A second cohort will explore the more promising histological type (if any) in term of incidence of detection. 100 patients are expected for this second cohort.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | blood sample for FSHR analysis | |
| PROCEDURE | blood sample for FSHR analysis |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2017-04-13
- Completion
- 2017-04-13
- First posted
- 2016-08-09
- Last updated
- 2023-08-24
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02860481. Inclusion in this directory is not an endorsement.